Recently, Hunan Huaxin Medical Device Co., Ltd. ("Huaxin Medical") announced that it had completed a Pre-B round of strategic financing of several hundred million yuan, led by IDG Capital and followed by Founder Securities Investment and Xiangtan Caixin Industrial Investment.

Founded in 2018, Huaxin Medical specializes in the fourth-generation medical endoscopes, medical specialty robots, and automated precision diagnosis and treatment systems characterized by ultra-miniaturization, high definition, and intelligence. Its research and development products mainly involve medical endoscopes and consumables for respiratory, urology, gastroenterology, anorectal, otolaryngology, gynecology, orthopedics, and other departments.

Headquartered in Hunan Xiangtan Economic and Technological Development Zone - Hunan Medical Device Industrial Park, Huaxin Medical is a national high-tech enterprise and a "small giant" enterprise specializing in innovation in Hunan Province. The company has established subsidiaries in Germany, Shanghai, Beijing, Wuhan, Changsha, Shenzhen, and other places. Olympus is the general agent of Huaxin Medical in the United States and an important strategic partner. In addition, the company has also established strategic partnerships with many world-renowned industrial giants. The company's innovative products are sold in dozens of developed countries and regions worldwide, including the United States, Germany, Japan, France, the United Kingdom, Australia, and its business scope covers the globe.

Dr. Zhou Zhenhua, Chairman of Huaxin Medical, said, "The birth of disposable endoscope products is a new blue ocean opportunity explored at the edge of the red ocean market. Huaxin Medical shortens the long commercialization cycle through simplified product innovation and technological breakthroughs, creating value that benefits doctors and patients. Huaxin Medical, with a heart full of inclusiveness, enters the market humbly, allowing the development of disposable endoscope products to return to their original purpose as a productive tool to enhance doctors' and hospitals' treatment levels, thereby expanding the boundaries of medical care and achieving the co-creation and prosperity of the entire industry."

After the completion of this round of financing, the raised funds will be used to further expand the product research and development pipeline, increase investment in clinical trials, expand automated production lines, strengthen the international market sales layout, and continuously enhance Huaxin Medical's competitiveness in the field of disposable endoscopes. We are grateful to new and old shareholders for their recognition and support of Huaxin Medical. After IDG Capital, Founder Securities Investment, and Xiangtan Caixin Industrial Investment became shareholders of Huaxin, the company's shareholder structure has become increasingly diversified. Each shareholder will also deeply empower Huaxin Medical in business expansion, capital docking, and other aspects, helping Huaxin Medical grow into a leading enterprise in the disposable endoscope industry.

About IDG Capital

IDG Capital is a leading global private equity investment institution that pioneered venture capital investment in China in 1993. IDG Capital's investment scope in the medical field covers all stages from startup, growth, maturity, to mergers and acquisitions, with investment scales ranging from millions to hundreds of millions of US dollars. Over the years, IDG Capital has always paid close attention to the development of innovative medical devices. In the cardiovascular field, IDG has invested in Huihe Medical, Yuanxin Technology, and Weimu Medical. In the field of medical robots, IDG has invested in Changgugu and Shuzhidao. In the field of new technologies, IDG has invested in cardiovascular AI solution provider Keya Medical and quantum magnetic field medical application-focused Weici Technology.

About Founder Securities Investment

Founder Securities Investment Co., Ltd. (hereinafter referred to as "Founder Securities Investment") is an alternative investment subsidiary wholly owned by Founder Securities Co., Ltd. It engages in equity investment business with its own funds, mainly focusing on national key encouraged industries such as healthcare, high-end manufacturing, and new-generation information technology.

About Xiangtan Caixin Industrial Investment

Hunan Xiangtan Caixin Industrial Investment Equity Investment Partnership (Limited Partnership) (hereinafter referred to as "Xiangtan Caixin Industrial Investment") is an industrial guidance fund jointly established by Hunan Caixin Financial Holding Group and Xiangtan Industrial Investment Development Group. The fund manager, Hunan Caixin Industrial Fund Management Co., Ltd. (hereinafter referred to as "Caixin Industrial Fund"), is a wholly-owned subsidiary of Hunan Caixin Financial Holding Group Co., Ltd. (hereinafter referred to as "Caixin Financial Holding"), a provincial financial holding platform in Hunan Province. Founded in January 2001, Caixin Industrial Fund is one of the first venture capital institutions in Hunan Province. Its business scope includes entrusted management of private equity funds and equity investment funds, entrusted asset management, investment management, venture capital investment, equity investment, etc. It is an important investment platform for Hunan Province to innovate the reform of fiscal investment and financing systems